Objective: To summarize key changes in the 2007 American College of Cardiology/American Heart Association (ACC/AHA) guideline recommendations for pharmacologic therapy as they relate to antiplatelets ...
PARSIPPANY, N.J. and INDIANAPOLIS, March 29, 2011 /PRNewswire/ -- Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended ...
DALLAS, TX and WASHINGTON, DC — The American Heart Association and the American College of Cardiology have issued a guideline for the management of patients with non-ST-elevation acute coronary ...
The American College of Cardiology and the American Heart Association have jointly released revised Guidelines for the Management of Patients with Unstable Angina (UA)/Non-ST- Elevation Myocardial ...
MUNICH, Germany—A new analysis from the large SCAAR registry in Sweden is once again challenging the role of pretreatment with oral P2Y12 receptor antagonists in PCI patients, this time zeroing in on ...
Ticagrelor, a blood-thinning drug approved by the FDA in 2011, should be considered along with older blood thinners clopidogrel and prasugrel for treating patients who are experiencing chest pain or ...
Unstable angina, or acute coronary syndrome, is a type of chest pain or discomfort that typically occurs when a person is resting. Unstable angina is a medical emergency, and people should seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results